Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19

Patients with COVID-19 present with a wide variety of clinical manifestations. Thromboembolic events constitute a significant cause of morbidity and mortality in patients infected with SARS-CoV-2. Severe COVID-19 has been associated with hyperinflammation and pre-existing cardiovascular disease. Pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolidis, Sokratis A., Sarkar, Amrita, Giannini, Heather M., Goel, Rishi R., Mathew, Divij, Suzuki, Aae, Baxter, Amy E., Greenplate, Allison R., Alanio, Cécile, Abdel-Hakeem, Mohamed, Oldridge, Derek A., Giles, Josephine R., Wu, Jennifer E., Chen, Zeyu, Huang, Yinghui Jane, Belman, Jonathan, Pattekar, Ajinkya, Manne, Sasikanth, Kuthuru, Oliva, Dougherty, Jeanette, Weiderhold, Brittany, Weisman, Ariel R., Ittner, Caroline A. G., Gouma, Sigrid, Dunbar, Debora, Frank, Ian, Huang, Alexander C., Vella, Laura A., Reilly, John P., Hensley, Scott E., Rauova, Lubica, Zhao, Liang, Meyer, Nuala J., Poncz, Mortimer, Abrams, Charles S., Wherry, E. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928747/
https://www.ncbi.nlm.nih.gov/pubmed/35309299
http://dx.doi.org/10.3389/fimmu.2022.834988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928747/
https://www.ncbi.nlm.nih.gov/pubmed/35309299
http://dx.doi.org/10.3389/fimmu.2022.834988

Ejemplares similares